ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Curtana and Catalent Enter Brain Cancer Drug Partnership contractpharma
July 19, 2021Curtana has signed an agreement with Catalent to support tablet formulation and manufacturing of Curtana’s CT-179, a drug therapy for the treatment of glioblastoma (GBM), medulloblastoma (MB), and other brain cancers.
Pharma Sources Insight January 2025
